Home › Funds › Point72 Asset Management › EXEL
Point72 Asset Management position in EXEL
EXELIXIS INC · Health Care
Latest position (Q4 2025)855.98K sh
Reported value held$37.52M
Portfolio Weight0.04%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 2.13M | $45.08M | New |
| Q4 2021 | 4.22M | $77.18M | Add |
| Q1 2022 | 7.26M | $164.68M | Add |
| Q2 2022 | 922.60K | $19.21M | Reduce |
| Q3 2022 | 923.70K | $14.48M | Hold |
| Q4 2022 | 6.42M | $103.04M | Add |
| Q1 2023 | 4.38M | $85.03M | Reduce |
| Q2 2023 | 5.91M | $112.89M | Add |
| Q3 2023 | 3.25M | $71.10M | Reduce |
| Q4 2023 | 2.60M | $62.29M | Reduce |
| Q3 2024 | 200.00K | $5.19M | New |
| Q4 2025 | 855.98K | $37.52M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding EXEL
- BlackRock Inc 29.08M sh · $1.58B · Q2 2026
- Vanguard Group 25.49M sh · $1.12B · Q4 2025
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- Renaissance Technologies 13.43M sh · $730.62M · Q2 2026
- AQR Capital Management 11.02M sh · $598.60M · Q2 2026
- Geode Capital Management 7.65M sh · $416.32M · Q2 2026
- D. E. Shaw & Co 5.55M sh · $302.07M · Q2 2026
- Morgan Stanley 4.52M sh · $245.92M · Q2 2026
- Invesco Ltd 4.50M sh · $244.61M · Q2 2026
- Arrowstreet Capital 4.37M sh · $237.55M · Q2 2026
- Two Sigma Investments 4.21M sh · $229.06M · Q2 2026
- UBS Group AG 3.17M sh · $172.36M · Q2 2026